Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobetaxolol for Glaucoma or Ocular Hypertension in Chinese Patients
NCT02617459Phase 3Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Jan 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levobetaxolol in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Zhaoke Ophthalmology. Started Jan 2019; status: completed.
02
Drugs
levobetaxolol
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02617459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617459.